Lenvatinib 10 mg Capsule

Lenvatinib 10 mg Capsule Specification

Dosage Form
Capsule

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 Capsules

Salt Composition
Levatinib

Drug Type
Other

Ingredients
Lenvatinib

Physical Form
Capsules

Function
Other

Dosage
10 mg

Dosage Guidelines
As per doctor suggestion

Storage Instructions
Room temperature

Lenvatinib 10 mg Capsule Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Packaging Details
4* 7 Tablets

Main Export Market(s)
Asia, Australia, Western Europe, Africa, Central America, Middle East, North America, South America, Eastern Europe

Main Domestic Market
All India

About Lenvatinib 10 mg Capsule

Lenvat 10mg Capsule contains the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment.

Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvat 10mg Capsule or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvat 10mg Capsule, as it can impair wound healing and increase the risk of bleeding.